Letters: No reason to stop scrips for anticholinergics

GP reports a study by Singh (JAMA 2008; 300: 1,439-50) on anticholinergic inhalers and CVD risk (GP, 26 September).

The study found no causal link between anticholinergic inhalers and CVD, but an association. The justification for the study came from the finding of a previous meta-analysis reported by the FDA which found that tiotropium was associated with an increased risk of stroke.

No association was found with stroke in the new study by Singh et al but, instead, a different set of associations was reported.

In our view, the Singh study has several methodological problems including double counting patients, comparing tiotropium to both active treatments and placebos and failing to account for increased drop-outs in the placebo arms as this resulted in a smaller risk of adverse events.

The findings of an increased risk of cardiovascular events are interesting, and merit further consideration, but are not a reason to change prescribing. The results of the UPLIFT study to be released this month may clarify the safety profile of tiotropium.

We believe Dr Yoon's comments in your article are completely inappropriate. GPs should not change the way they prescribe anticholinergic inhalers on the basis of this single study unless advised by independent bodies. There is no clinical rationale to prescribe anticholinergics for short-term use - they are to treat symptoms and prevent exacerbations of a long-term progressive condition.

Long-term benefits of anticholinergic inhalers have been demonstrated and are reported in UK national and all international guidelines. Dr Yoon's recommendations to GPs on the basis of his single study will cause unnecessary distress to patients and confusion to clinicians.

GPs should allow time for the findings to be considered in the light of other scientific data and reach a calm objective conclusion before they change their prescribing habits.

Professor David Price, professor of primary care respiratory medicine, Aberdeen University; Dr Rupert Jones, GP in Plymouth; Dr Dermot Ryan, GP in Loughborough; Dr Mike Thomas, GP in Gloucestershire; Dr Daryl Freeman, GP in Norfolk; Dr John Haughney, GP in Scotland.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs place first orders from government flu jab reserve as £12m support fund rolled out

GPs place first orders from government flu jab reserve as £12m support fund rolled out

GP practices can start ordering flu vaccine from an 8m-dose government stockpile...

Quarter of government's 8m-dose flu stockpile is vaccine granted temporary approval

Quarter of government's 8m-dose flu stockpile is vaccine granted temporary approval

A vaccine yet to be licensed in the UK accounts for more than a quarter of the 8m...

GPs report drop in older patients coming forward with cancer symptoms

GPs report drop in older patients coming forward with cancer symptoms

More than half of GPs say numbers of older patients coming forward with cancer symptoms...

Failure to involve GPs in COVID-19 test and trace 'a disaster and a national shame'

Failure to involve GPs in COVID-19 test and trace 'a disaster and a national shame'

GPs and primary care teams should have played a key role in the UK’s efforts to test,...

RCGP chair 'livid' over attacks on general practice from 'armchair critics'

RCGP chair 'livid' over attacks on general practice from 'armchair critics'

General practice has risen 'heroically' to unprecedented challenges during the COVID-19...

Remote GP consultations a 'lifeline for the NHS' during pandemic, says Hancock

Remote GP consultations a 'lifeline for the NHS' during pandemic, says Hancock

The rapid switch to remote GP consultations during the COVID-19 pandemic provided...